Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine

被引：0
|
作者：
Amanda Jane Leach
Christine Wigger
Kim Hare
Vanya Hampton
Jemima Beissbarth
Ross Andrews
Mark Chatfield
Heidi Smith-Vaughan
Peter Stanley Morris
机构：
[1] Charles Darwin University,Menzies School of Health Research
[2] Royal Darwin Hospital,undefined
来源：
BMC Pediatrics | / 15卷
关键词：
Nasopharynx; Nontypeable ; Otitis media; child; Indigenous; Pneumococcal vaccines; Prevalence; Surveillance; Risk factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Impact Estimate of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine (PHiD-CV) on Invasive Pneumococcal Disease (IPD) in Middle East and Asian Countries
    Hausdorff, W. P.
    Beckers, F.
    Dagan, R.
    Begg, N.
    Gatchalian, S.
    Schuerman, L.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E44 - E45
  • [32] Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial
    Dicko, Alassane
    Odusanya, Olumuyiwa O.
    Diallo, Abdoulbaki I.
    Santara, Gaoussou
    Barry, Amadou
    Dolo, Amagana
    Diallo, Aminata
    Kuyinu, Yetunde A.
    Kehinde, Omolara A.
    Francois, Nancy
    Borys, Dorota
    Yarzabal, Juan P.
    Moreira, Marta
    Schuerman, Lode
    BMC PUBLIC HEALTH, 2011, 11
  • [33] Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial
    Alassane Dicko
    Olumuyiwa O Odusanya
    Abdoulbaki I Diallo
    Gaoussou Santara
    Amadou Barry
    Amagana Dolo
    Aminata Diallo
    Yetunde A Kuyinu
    Omolara A Kehinde
    Nancy François
    Dorota Borys
    Juan P Yarzabal
    Marta Moreira
    Lode Schuerman
    BMC Public Health, 11
  • [34] Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies
    Hammitt, Laura L.
    Akech, Donald O.
    Morpeth, Susan C.
    Karani, Angela
    Kihuha, Norbert
    Nyongesa, Sammy
    Bwanaali, Tahreni
    Mumbo, Edward
    Kamau, Tatu
    Sharif, Shahnaaz K.
    Scott, J. Anthony G.
    LANCET GLOBAL HEALTH, 2014, 2 (07): : E397 - E405
  • [35] Non-typeable Haemophilus influenzae empyema in the serotype b vaccine era
    Fernandez Rodriguez, B.
    Garcia Pimentel, B.
    Gonzalez-Granado, L. I.
    Negreira Cepeda, S.
    ANALES DE PEDIATRIA, 2010, 72 (05): : 360 - 362
  • [36] Immunogenicity of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) When Coadministered With Different Neisseria meningitidis Serogroup C Conjugate Vaccines
    Wysocki, Jacek
    Tejedor, Juan C.
    Grunert, Dutlef
    Konior, Ryszard
    Garcia-Sicilia, Jose
    Knuf, Markus
    Bernard, Laurence
    Dieussaert, Ilse
    Schuerman, Lode
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (04) : S77 - S88
  • [37] Non-typeable Streptococcus pneumoniae infection in a medical center after wide use of pneumococcal conjugate vaccine
    Hsu, M. -H.
    Hsu, T. -C.
    Li, H. -C.
    Su, L. -H.
    Chiu, C. -H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 50 : S119 - S119
  • [38] The 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Coadministered With DTPw-HBV/Hib and Poliovirus Vaccines: Assessment of Immunogenicity
    Bermal, Nancy
    Szenborn, Leszek
    Chrobot, Andrej
    Alberto, Edison
    Lommel, Patricia
    Gatchalian, Salvacion
    Dieussaert, Ilse
    Schuerman, Lode
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (04) : S89 - S96
  • [39] A COST EFFECTIVENESS ANALYSIS OF A GENERAL VACCINATION PROGRAMME WITH THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN SWEDEN
    Bergman, A.
    Borg, S.
    Sobocki, P.
    Persson, U.
    VALUE IN HEALTH, 2009, 12 (03) : A165 - A165
  • [40] Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trial
    Saez-Llorens, Xavier
    Rowley, Stella
    Wong, Digna
    Rodriguez, Mirna
    Calvo, Arlene
    Troitino, Marisol
    Salas, Albino
    Vega, Vielka
    Mercedes Castrejon, Maria
    Lommel, Patricia
    Pascal, Thierry G.
    Hausdorff, William P.
    Borys, Dorota
    Ruiz-Guinazu, Javier
    Ortega-Barria, Eduardo
    Yarzabal, Juan Pablo
    Schuerman, Lode
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (06) : 1213 - 1228
12345